Blog
Game-Changing Cancer Immunotherapy Deal Unveiled
📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝
AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!
Virtual Drug Discovery Firm Raises $35m in Seed Funding for Breakthrough Medicines
📢 Relation Therapeutics Ltd 💊 secures US$35m 💰 in seed financing! 🌱 Accelerating drug discovery for osteoporosis and more! 🧪🧬 biotech investment
Mind-Blowing Protein Holograms Reveal Molecular Secrets
🔍🔬⚛️ Oxford University researchers use holography to study proteins, improving sensitivity and measuring biomolecule polarity. Exciting breakthrough in nanoscience!
Revolutionizing Cell Therapy: Diversify Collaborate and Optimize
Title: 📝 Improving Cell Therapy Supply Chains: Insights from Pluri, an Israeli Cell Therapy Company Excerpt: Pluri advises advanced therapy manufacturers to diversify, collaborate, and build strong relationships with suppliers for optimal supply chains.
Master Your Biopharma Strategy: Avoid Over-Investing
📢 Process intensification in biopharma is complex and costly, but with data-driven strategies and step-by-step implementation, success is possible! 💪💰📈
Boosting Lyophilization Productivity by 300: A Game-Changing Digital Twin Approach
📰 Researchers at Clausthal University of Technology in Germany have found that using a digital twin approach during the freeze-drying process for biologics can increase productivity by up to 300 🚀💰. This approach also reduces costs by 74 💵 and lowers the global warming potential by 64 🌍. Lyophilization DigitalTwin
Supercharging Bioprocessing with Microbes: The Future of Genetic Engineering
Getting More from Microbes explores the 🧫 world of microbial systems in bioprocessing and the 🧬 development of innovative cell lines. 🚀
Revolutionary Partnership: Gene Therapy for Hemophilia
ReciBioPharm teams up with GeneVentiv to create a groundbreaking gene therapy for hemophilia treatment. 🧬🔝✅
Groundbreaking Discovery for Atherosclerosis Prevention Revealed
📢 Researchers have found that TREM2 could help reduce necrotic core formation in early atherosclerosis, preventing heart attacks and stroke. 💉💡
